Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 289.6B | 309.2B | 298.5B | 337.1B |
Cost of revenue | 271.8B | 306.0B | 280.8B | 302.6B |
Gross profit | 17.8B | 3.2B | 17.7B | 34.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 16.0B | -12.4B | 15.6B | 15.6B |
Other operating expenses | — | — | — | — |
Operating income | 17.8B | -16.7B | 2.1B | 18.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.9B | 1.3B | 17.4B | 21.8B |
Tax provision | -875.6M | 2.7B | 1.1B | 5.0B |
Net income | 6.8B | -1.4B | 16.3B | 16.8B |
Basic EPS | 392.5 | — | 897 | 875 |
Diluted EPS | 392.5 | — | 897 | 875 |
Basic average shares | — | — | 17.5M | 17.4M |
Diluted average shares | — | — | 17.5M | 17.4M |
EBITDA | 17.8B | 25.8B | 2.1B | 18.9B |
Net income from continuing op. | — | -1.4B | 16.3B | 16.8B |
Minority interests | -181.2M | 220.3M | -682.7M | -1.5B |
Preferred stock dividends | — | — | — | — |